<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1695-6141</journal-id>
<journal-title><![CDATA[Enfermería Global]]></journal-title>
<abbrev-journal-title><![CDATA[Enferm. glob.]]></abbrev-journal-title>
<issn>1695-6141</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Murcia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1695-61412017000100491</article-id>
<article-id pub-id-type="doi">10.6018/eglobal.16.1.260411</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectividad del tratamiento tópico de la flebitis secundaria a la cateterización periférica: una revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Efectiveness of topical therapies for phlebitis related to peripheral intravenous canulation: a sistematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martín Gil]]></surname>
<given-names><![CDATA[Belén]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández Castro]]></surname>
<given-names><![CDATA[Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Vallecillo]]></surname>
<given-names><![CDATA[Maria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peña García]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Clínico Universitario de Valladolid Unidad de Oncología Radioterápica y Medicina Nuclear ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Clínico Universitario de Valladolid Unidad de Gestión de Cuidados GACELA CARE ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2017</year>
</pub-date>
<volume>16</volume>
<numero>45</numero>
<fpage>491</fpage>
<lpage>507</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1695-61412017000100491&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1695-61412017000100491&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1695-61412017000100491&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción  La flebitis es la complicación más frecuente secundaria a la cateterización periférica.  Objetivo  Evaluar la evidencia disponible sobre la efectividad de tratamientos tópicos de la flebitis post-perfusión en pacientes portadores de catéter venoso periférico.  Método  Se realizó revisión sistemática de ensayos clínicos y revisiones sistemáticas publicados desde 1995 a 2015 en las bases de datos Pubmed, Cinahl, Cochrane plus CUIDEN y la BVS (Biblioteca Virtual en Salud), en inglés y español. Los criterios de inclusión fueron: paciente adulto hospitalizado, portador de vía venosa periférica, con perfusión continua o intermitente, incluyendo todo tipo de terapia de infusión que hubieran desarrollado cualquier grado de flebitis. La valoración de la calidad metodológica de los estudios seleccionados, se realizó por pares de forma independiente utilizando el Clinical Appraisal Skills Programme en su versión española.  Resultados  Se seleccionaron 11 estudios: 8 ensayos clínicos y 3 revisiones sistemáticas. Analizaron los efectos de fitoterapéuticos: aloe vera, chamomilla recutita y notoginseny; pomadas heparinoides y geles de heparina; antiinflamatorios como el diclofenaco y vasodilatadores como la nitroglicerina, resultando todos ellos efectivos.  Conclusiones  El aloe vera, notoginseny, diclofenaco y heparina gel 1000 UI, mostraron nivel de evidencia y grado de recomendación moderado. La heparina gel es el único compuesto con indicación de la Agencia Española del Medicamento para tratar la flebitis post-perfusión, el notoginseny no está comercializado en Occidente y el diclofenaco es un antiinflamatorio utilizado en diversas patologías. Es merecedor de especial atención el tratamiento con aloe vera a la espera de estudios más concluyentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background  Phlebitis is the most common complication induced by peripheral intravenous catheter.  Aim  To assess the best available evidence concerning the effectiveness of topical therapies in patients with peripheral venous canulation who developed phlebitis  Method  The bibliographic search for clinical trials and sistematic reviews, published between 1995 and 2015, was carried out in the following databases Pubmed, Cinahl, Cochrane plus CUIDEN and BVS (Biblioteca Virtual en Salud), in english and spanish. Inclusion criteria were: adult inpatient with peripheral venous cateterization with continous or intermitent infusion, including all types of infusion therapy who developed any degree of superficial phlebitis. The quality of selected studies was assessed independently by peer reviewers using the Clinical Appraisal Skills Programme in its spanish version.  Results  11 studies were identified, 8 clinical trials and 3 sistematic reviews. The efectiveness of topical phytotherapeutics: aloe vera, chamomilla recutita and notoginseny; heparinoid creams and heparin gels; anti-inflamatory as diclofenac, and vasodilators as nitroglycerin was analized, showing effectivity all of them.  Conclusions  Aloe vera, notoginseny, diclofenac and heparine gel suggest a weak level of evidence and moderate grade of recommendation. Heparin gel is the only product provided by the Spanish Medicine Agency to treat post-infusion phlebitis, notoginseny is not marketed in Spain and diclofenac is an anti-inflammatory used for various pathologies. Deserves special attention of topical therapy with aloe vera but further studies are needed.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Flebitis]]></kwd>
<kwd lng="es"><![CDATA[tratamiento]]></kwd>
<kwd lng="es"><![CDATA[catéter periférico]]></kwd>
<kwd lng="es"><![CDATA[infusión intravenosa]]></kwd>
<kwd lng="en"><![CDATA[Phlebitis]]></kwd>
<kwd lng="en"><![CDATA[treatment]]></kwd>
<kwd lng="en"><![CDATA[peripheral catéter]]></kwd>
<kwd lng="en"><![CDATA[intravenous infusion]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas-Sánchez]]></surname>
<given-names><![CDATA[L Z]]></given-names>
</name>
<name>
<surname><![CDATA[Parra]]></surname>
<given-names><![CDATA[D I]]></given-names>
</name>
<name>
<surname><![CDATA[Camargo-Figuera]]></surname>
<given-names><![CDATA[F A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia y factores asociados al desarrollo de flebitis resultados del estudio piloto de una cohorte]]></article-title>
<source><![CDATA[Referencia]]></source>
<year>2015</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>61-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mestre Roca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Berbel Bertolo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tortajada Lopez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gallemi Samaranch]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar Ramírez]]></surname>
<given-names><![CDATA[M A]]></given-names>
</name>
<name>
<surname><![CDATA[Caylà Buqueras]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessing the influence of risk factors on rates and dynamics of peripheral vein phlebitis An observational cohort study]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2012</year>
<volume>139</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>185-91</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cicolini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Manzoli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Simonetti]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Flacco]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Comparcini]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Capasso]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phlebitis risk varies by peripheral venous catéter site and increases after 96 hours a large multi-centre prospective study]]></article-title>
<source><![CDATA[J Adv Nurs]]></source>
<year>2014</year>
<volume>70</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2539-49</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Piazuelo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Almela]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Blecua]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gallardo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of add-on devices for the prevention of phlebitis and other complications associated with the use of peripheral catheters in hospitalised adults a randomised controlled study]]></article-title>
<source><![CDATA[J Hosp Infect]]></source>
<year>2009</year>
<volume>73</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>135-42</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hadaway]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short peripheral intravenous catheters and infections]]></article-title>
<source><![CDATA[J Infus Nurs]]></source>
<year>2012</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>230-40</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marsh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mihala]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[&gt;Ray-Barruel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rickard]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inter-rater agreement on PIVC associated phlebitis signs, symtoms and scales]]></article-title>
<source><![CDATA[J Eval Clin Pract]]></source>
<year>2015</year>
<volume>21</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>893-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woody]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increasing nurse competence in peripheral intravenous therapy]]></article-title>
<source><![CDATA[J Infus Nurs]]></source>
<year>2013</year>
<volume>36</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>413-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Almirante]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous catheter-related infections]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2014</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-24</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González López]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Arribi Vilela]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández del Palacio]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Olivares Corral]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Benedicto Martí]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera Portal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters a randomized study]]></article-title>
<source><![CDATA[J Hosp Infect]]></source>
<year>2014</year>
<volume>86</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>117-26</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stuart]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kotsanas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Grayson]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Korman]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia more than 5 years of prospective data from two tertiary health services]]></article-title>
<source><![CDATA[Med J Aust]]></source>
<year>2013</year>
<volume>198</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>551-3</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrete-Morales]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez-Pérez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Berna]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gilabert-Cerro]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Corzo-Delgado]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Pineda-Vergara]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of phlebitis due to peripherally inserted venous catheters impact of a catheter management protocol]]></article-title>
<source><![CDATA[Enferm Clin]]></source>
<year>2010</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dochterman]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Bulechek]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Butcher]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
</person-group>
<source><![CDATA[Clasificación de intervenciones de enfermería (NIC)]]></source>
<year>2013</year>
<edition>5</edition>
<page-range>764</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier Mostby]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Duell]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
</person-group>
<source><![CDATA[Técnicas de enfermería clínica. De las técnicas básicas a las avanzadas]]></source>
<year>2009</year>
<volume>Vol II</volume>
<edition>7</edition>
<page-range>1097</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Pearson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Corrigan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gorskil]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hankins]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Perucca]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Infusion nursing and evidence-based approach]]></source>
<year>2010</year>
<edition>3ª ed.</edition>
<page-range>475</page-range><publisher-loc><![CDATA[Missouri ]]></publisher-loc>
<publisher-name><![CDATA[Saunder Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ingram]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lavery]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peripheral intravenous therapy key risks and implications for practice]]></article-title>
<source><![CDATA[Nurs Stand]]></source>
<year>2005</year>
<volume>19</volume>
<numero>46</numero>
<issue>46</issue>
<page-range>55-64</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tjon]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Ansani]]></surname>
<given-names><![CDATA[NT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transdermal nitroglycerin for the prevention of intravenous infusion failure due to phlebitis and extravasation]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2000</year>
<volume>34</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1189-92</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Grupo de trabajo de la Guía de Práctica Clínica sobre Terapia Intravenosa con Dispositivos no Permanentes en Adultos</collab>
<source><![CDATA[Guía de Práctica Clínica sobre Terapia Intravenosa con Dispositivos no Permanentes en Adultos]]></source>
<year>2014</year>
<publisher-name><![CDATA[Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía (AETSA)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<source><![CDATA[Guías CASPe de Lectura Crítica de la Literatura Médica CASPe]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<collab>Joanna Briggs Institute JBI CONNECT España</collab>
<source><![CDATA[Centre collaborador espanyol del JBI]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[PED Dos]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[EC de]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[PCP]]></given-names>
</name>
<name>
<surname><![CDATA[Bastos]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical application of Chamomilla recutita in phlebitis dose response curve study]]></article-title>
<source><![CDATA[Rev Lat Am Enfermagem]]></source>
<year>2011</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-10</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gouping]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Wan-Er]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Xue-Ling]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Min-Qian]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Kun]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Turale]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Notoginseny cream in the treatment of phlebitis]]></article-title>
<source><![CDATA[J Infus Nurs]]></source>
<year>2003</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-54</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becherucci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bagilet]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Marenghini]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Diab]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2000</year>
<volume>114</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>371-3</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vilardell]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sabat]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Arnaiz]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Bleda]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Castel]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Laporte]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Vallvé]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial]]></article-title>
<source><![CDATA[Eur J Clin Pharmacol]]></source>
<year>1999</year>
<volume>54</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>917-21</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Sanctis]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Cesarone]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Incandela]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Belcaro]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of superficial vein thrombophlebitis of the arm with Essaven gel--a placebo-controlled, randomized study]]></article-title>
<source><![CDATA[Angiology]]></source>
<year>2001</year>
<volume>52</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>S63-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz Trillo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Borrero Esteban]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamientos aplicados a la Flebitis posperfusión]]></article-title>
<source><![CDATA[Rev ROL Enferm]]></source>
<year>2006</year>
<volume>29</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>55-60</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[IHL]]></given-names>
</name>
<name>
<surname><![CDATA[Jabin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Best Treatment Modality for Superficial Phlebitis]]></article-title>
<source><![CDATA[Ann Acad Med Singapore]]></source>
<year>2010</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>S2010</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Córcoles]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Flebitis postpunción]]></article-title>
<source><![CDATA[Rev ROL Enferm]]></source>
<year>1996</year>
<volume>217</volume>
<page-range>13-6</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Mei]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aloe vera for prevention and treatment of infusion phlebitis]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2014</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[PED Dos]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Vasques]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[EC de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacological interventions to treat phlebitis systematic review]]></article-title>
<source><![CDATA[J Infus Nurs]]></source>
<year>2009</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>74-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di Nisio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Peinemann]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Porreca]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rutjes]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment for superficial infusion thrombophlebitis of the upper extremity]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2015</year>
<volume>11</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
